Sunil Bhonsle | President and Chief Executive Officer |
Jennifer Kiernan | Executive Assistant to Chief Executive Officer and Investor Communications Coordinator |
Marc Rubin | Executive Chairman |
Dane Hallberg | Executive Vice President and Chief Commercial Officer |
Katherine DeVarney | Executive Vice President and Chief Scientific Officer |
Brian Crowley | Vice President of Finance and Administration |
John Vandermosten | Zacks Small Cap Research |
Benjamin Haynor | Alliance Global Partners |
Thank you for holding, and welcome to the Titan Pharmaceuticals' Third Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session following today's remarks. Please be advised that this call is being taped at the Company's request and will be archived on the Company's website starting later today.
At this time, I would like to turn the call over to Sunil Bhonsle, President and CEO of Titan Pharmaceuticals.